The overall hypothesis of EPIVIRCO is that SARS-CoV-2 induces epigenetic dysregulation that altersimmunity to co-pathogens and drives neuropathological processes and that such epigeneticmechanisms could be the targets of therapeutic intervention.
ENTITATS FINANÇADORES
Convocation
CaixaResearch Health Call 2021-2022 - EPIVIRCO
Science to feed the future.
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.